Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a ...

William Blair initiated coverage of Rubrik (RBRK) with a Market Perform rating.Maximize Your Portfolio with Data Driven Insights:Leverage the ...

Analysts at William Blair raised their Q1 2025 EPS estimates for Kforce in a research report issued to clients and investors on Tuesday, February 4th. William Blair analyst T. Romeo now anticipates ...

Research analysts at William Blair issued their FY2025 earnings per share estimates for shares of Marvell Technology in a research note issued to investors on Wednesday, February 5th. William Blair ...

William Blair initiated coverage on Mersana Therapeutics, Inc. (NASDAQ:MRSN) with an Outperform rating. The firm's analyst cited the company's potential in the antibody-drug conjugates (ADCs) market ...

WJCC Schools last changed the name of one of its schools in 2017. Before it was Laurel Lane Elementary, the elementary school ...

According to a report by Reuters on January 23, the number of citizens in the United States applying for unemployment ...

EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma.

Props to BOB GORDON, MALCOLM MCKAY, ROBERT MCDOUGALL, GORDAN RANDALL, RAY DEL BIANCO, SHAUGHN MCARTHUR, MARCEL MARCOTTE, ...